CPG
MACK

Cornerstone Planning Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Cornerstone Planning Group’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-231
Closed – – 1393
2024
Q2 		$0 Hold
231
– – ﹤0.01% 1364
2024
Q1 		$3.47K Buy
+231
New +$3.47K ﹤0.01% 579